Debevoise Files Amicus Brief Asking 4th Circuit to Bar Unnecessary Restrictions to Mifepristone Access in North Carolina
October 24, 2024
October 24, 2024
NEW YORK, Oct. 24 -- Debevoise and Plimpton, a law firm, issued the following news:
Debevoise & Plimpton LLP has filed an amicus curiae brief in the Fourth Circuit Court of Appeals on behalf of the nation's leading medical societies in an effort to protect access to mifepristone, a drug commonly used in medication abortion and miscarriage care. North Carolina has imposed several barriers to mifepristone access which the Food and Drug Administration ("FDA") already cons . . .
Debevoise & Plimpton LLP has filed an amicus curiae brief in the Fourth Circuit Court of Appeals on behalf of the nation's leading medical societies in an effort to protect access to mifepristone, a drug commonly used in medication abortion and miscarriage care. North Carolina has imposed several barriers to mifepristone access which the Food and Drug Administration ("FDA") already cons . . .